Loading stock data…
$38.61
BioLife Solutions, Inc.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $28.47M↑ | $27.50M↑ | $18.79M↓ | $28.07M↑ | $23.44M |
| Gross Profit | $18.29M↑ | $17.50M↑ | $11.98M↓ | $17.92M↑ | $15.23M |
| Operating Income | $1.70M↑ | $27,000↓ | $1.35M↑ | -$89,000↑ | -$16.13M |
| Net Income | $45.10M↑ | $1.19M↓ | $11.07M↑ | $621,000↑ | -$15.84M |
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used i...